The Curious Case Of Elliott Advisors And GSK: Are Activist Investors What They Used To Be? Elliott Advisors supports GSK's plans to split into two companies and has made five recommendations. One is that a refreshed board do an internal and external search for the CEO of New GSK. Many are interpreting this as an attack on CEO Emma Walmsley. It is not. It is just good corporate governance.